Month: September 2021

Patriot Glass Solutions, a Division of C-Bond Systems, Names its First Three Distributors to its Network of Security and Ballistic-Resistant Window Film Providers

Written by Customer Service on September 22, 2021. Posted in Public Companies.

C-Bond’s Ballistic-Resistant Film System, Validated to Provide NIJ Level I, Level II, and Level IIA Protection, Addresses the Growing Need for Security Film Due to an Increase in Looting, Rioting, and Shootings HOUSTON, Sept. 22, 2021 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced its Patriot Glass Solutions division has added three new distributors to its network of security and ballistic-resistant window film providers. The well-established distributors are geographically diverse, located in certain markets in Colorado, California, Michigan, Texas, Utah, Kansas, and Missouri. Patriot Glass Solutions protects personal, commercial and government property from looting, rioting, break-ins, and gunfire. Its leading products are C-Bond BRS, a ballistic-resistant...

Akari Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Clinical Progress

Written by Customer Service on September 22, 2021. Posted in Earnings Releases And Operating Results.

Currently opening sites for Phase III study of nomacopan in bullous pemphigoid (BP).Phase III study of nomacopan in severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) open for enrollment.Evaluating the potential for long-acting PAS-nomacopan as a treatment for dry age-related macular degeneration (AMD).Collaborating with clinical partners to explore potential for treating exacerbations in severe lung diseases where inhaled nomacopan can be potentially delivered directly to the lung.Active pipeline exploring treatment of head trauma with nomacopan and the development of votucalis, a new anti-histamine biopharmaceutical with a similar structure to nomacopan.NEW YORK and LONDON, Sept. 22, 2021 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical...

3PL Market worth USD 1,993.72 billion by 2028, registering a CAGR of 8.7% – Report by Market Research Future (MRFR)

Written by Customer Service on September 22, 2021. Posted in Mergers And Acquisitions.

New York, Sept. 22, 2021 (GLOBE NEWSWIRE) — 3PL Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “3PL Market Research Report, Service, Mode of Transport, Application and Region – Forecast till 2028” the market is projected to be worth USD 1,993.72 billion by 2028, registering a CAGR of 8.7% during the forecast period (2021 – 2028), The market was valued at USD 921.49 billion in 2020. Key Players Notable players profiled in the global third-party logistics market report areC.H. Robinson Worldwide (US) BDP International Inc. (US) CEVA Logistics (Switzerland) FedEx Corporation (US) DSV Panalpina A/S (Denmark) Burris Logistics (US) DB Schenker Logistics (Germany) DHL International GmbH (Germany) Nippon Express (Japan) Kerry Logistics (Hong Kong). Get Free Sample PDF Brochure https://www.marketresearchfuture.com/sample_request/9996...

NevGold Announces U.S. Listing on OTCQB and Receives DTC Eligibility

Written by Customer Service on September 22, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQB:NAUFF) (Frankfurt:5E50) is pleased to announce that its shares will commence trading under the symbol “NAUFF” on the OTCQB Venture Market (the “OTCQB”) effective September 22, 2021. The Company has also received The Depository Trust Company (the “DTC”) full-service eligibility in the United States, making the Company’s stock more accessible to U.S. retail and institutional investors. NevGold CEO, Brandon Bonifacio, comments: “Listing on the OTCQB, along with our Frankfurt, Germany listing, enables our U.S. and European shareholders to more effectively participate in trading NevGold shares and will increase liquidity in multiple jurisdictions. With our Limousine Butte and Cedar Wash gold projects in Nevada,...

Pluristem CEO Issues Shareholder Update

Written by Customer Service on September 22, 2021. Posted in Public Companies.

Figure 1Clinical Pipeline: MilestonesHAIFA, Israel, Sept. 22, 2021 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company, today issued an update to its shareholders from its Chief Executive Officer and President Yaky Yanay. Dear Shareholders, Less than three months into a new fiscal year, there are several important developments on the horizon for Pluristem, including four studies heading to clinical readout in the coming quarters. These studies align with our mission to develop novel cell therapy product candidates, built using Pluristem’s advanced technology. Clinical Pipeline: Milestones During the coming year, we expect to meet multiple clinical milestones, which represent significant potential for our cellular platform. First, our Phase I study evaluating...

Save Foods Successfully Completes Lemon Pilot Tests in Spain

Written by Customer Service on September 22, 2021. Posted in Public Companies.

Pilot tests were conducted together with a leading service provider in the post-harvest space TEL AVIV, Israel, Sept. 22, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Save Foods (Nasdaq: SVFD) (“Save Foods” or the “Company”), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure food safety of fresh fruits and vegetables, today announced that it successfully completed a series of lemon treatment pilot tests in Spain, with a leading post-harvest service provider (“the Provider”). Spain is the leading European country in terms of lemon production, with a total of 1.2 million tons in 2020; that is 64% of the EU’s total lemon production. Spain is the largest lemon exporter in the world, accounting for approximately 27% with an estimated market...

Theratechnologies Announces Positive Results for Trogarzo® IV Push Administration Study

Written by Customer Service on September 22, 2021. Posted in Public Companies.

– TMB-302 study results demonstrate that there was no difference in pharmacokinetics between IV Push and IV Infusion – – No serious adverse events observed – – sBLA filing planned for Q4 2021 – MONTREAL, Sept. 22, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that a study evaluating an intravenous (IV) push form of administration of Trogarzo® for the treatment of human immunodeficiency virus type 1 (HIV-1) infection achieved consistent and statistically significant results demonstrating that there was no difference in pharmacokinetics (PK) between IV Push and IV Infusion. Based on these results, a supplemental Biologics...

Akoya Biosciences Appoints Diagnostics Industry Pioneer Myla Lai-Goldman, MD, to its Board of Directors

Written by Customer Service on September 22, 2021. Posted in Public Companies.

Myla Lai-Goldman, MDAkoya Biosciences appoints Myla Lai-Goldman, MD, to its Board of Directors.MARLBOROUGH, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true pioneer and leader in the diagnostic industry, to its board of directors. “It is an honor to join the board of Akoya, a company that is providing innovative spatial biology solutions with the potential to transform the life sciences market,” said Dr. Lai-Goldman. “Akoya’s platforms provide an unprecedented capability to understand the relationship of cells to their tumor microenvironment, and span applications from discovery and clinical research. The groundbreaking discoveries emanating from this work could dramatically increase...

Xeriant and XTI Aircraft sign LOI to pursue Merger

Written by Customer Service on September 22, 2021. Posted in Mergers And Acquisitions.

BOCA RATON, Fla., Sept. 22, 2021 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTCQB: XERI) (“Xeriant”), an aerospace company dedicated to Advanced Air Mobility, and XTI Aircraft Company (“XTI”), an OEM and developer of the TriFan 600, a leading next-generation hybrid-electric VTOL aircraft, announced today that they have executed a Letter of Intent (the “LOI”) to pursue a merger whereby Xeriant would acquire 100% of the issued and outstanding shares of XTI. The LOI provides for the parties to negotiate and enter into a definitive merger agreement by October 22, 2021. Xeriant has retained Maxim Group LLC as its financial advisor to assist the Company in its endeavors, including its pursuit of an uplisting of Xeriant’s common stock to a national exchange. Xeriant and XTI intend to announce the definitive terms of the merger agreement once finalized...

Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

Written by Customer Service on September 22, 2021. Posted in Public Companies.

NEWARK, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference being held virtually September 27-30, 2021. Additional details can be found below: Date: Thursday, September 30, 2021Time: 10:00 a.m. ETLocation: Webcast Link – or at the company’s website (click here) A replay of the presentation will be available by visiting the “Events & Presentations” section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days. About Rain Therapeutics Inc.Rain Therapeutics Inc. is a late-stage precision...

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Month: September 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals